Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demannose SCHEMBL20898460 | 1.00 | PDE4A (0.45) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL5858806 | 1.00 | PDE4A (0.45) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL15066417 | 0.96 | PDE4A (0.42) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Xylose SCHEMBL8325038 | 0.94 | PDE4A (0.42) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL3630269 | 0.94 | PDE4A (0.50) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL13277644 | 0.94 | PDE4A (0.50) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL8560244 | 0.94 | PDE4A (0.50) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL21456966 | 0.94 | PDE4A (0.50) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Galactose SCHEMBL423422 | 0.94 | PDE4A (0.50) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Demannose SCHEMBL29395609 | 0.94 | PDE4A (0.50) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120035431-A | Cosmetic composition comprising natural resin | 莱雅公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-117099957-A | Use of rhizoma Polygonati aqueous extract under high-fat diet as intestinal flora prebiotic and its product | 陇东学院 | 2023-11-24 | — | — | CN | disclosed |
| CN-109863244-B | GH9 endoglucanase variants and polynucleotides encoding same | 诺维信公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-115737462-A | Composition for keratin fibers | 莱雅公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-105828882-B | Packaging article comprising an envelope and an anhydrous dye composition comprising a direct dye, use thereof and process for dyeing keratin fibres | 莱雅公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-108430442-B | Method for treating keratin fibres comprising the application of a composition comprising urea or a derivative thereof, a polyol and an aminosilicone | 欧莱雅 | 2022-08-09 | — | — | CN | disclosed |
| CN-114745956-A | Composition comprising 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one, a preservative and/or antioxidant, a surfactant and a polymer, and method for treating keratin materials using this composition | 莱雅公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-108350443-B | Polypeptides having xanthan degrading activity and polynucleotides encoding same | 诺维信公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-105828883-B | Method for treating keratin fibres using a packaging article comprising an envelope and an anhydrous composition comprising an oxidizing agent | 莱雅公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-105828884-B | Packaging article comprising an envelope and an anhydrous dye composition comprising an oxidation dye, use thereof and process for dyeing keratin fibres | 莱雅公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-111278971-A | GH9 endoglucanase variants and polynucleotides encoding same | 诺维信公司 | 2020-06-12 | — | — | CN | disclosed |
| US-7015206-B2 | Use of a polysaccharide excreted by the Vibrio diabolicus species in bone repair | INSTITUT FRANCAIS DE LE RECHERCHE POUR L'EXPLOITATION DE LA MER (FR) | 2006-03-21 | — | — | US | disclosed |
| EP-1171625-B1 | PURIFIED \"ALTEROMONAS MACLEODII\" POLYSACCHARIDE AND ITS USES | INST FRANCAIS DE RECH POURL EX (FR) | 2005-01-19 | — | — | EP | disclosed |
| US-20040030403-A1 | Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair | INSTITUT FRANCAIS DE LA RECHERCHE POUR L'EXPLOITATION DE LA MER (FR) | 2004-02-12 | — | — | US | disclosed |
| EP-0584206-B1 | GENETIC CONTROL OF ACETYLATION OF XANTHAN BASED POLYSACCHARIDE POLYMERS | MONSANTO CO (US) | 2003-07-30 | — | — | EP | disclosed |
| US-6545145-B1 | In human and animal foods | INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER) (FR) | 2003-04-08 | — | — | US | disclosed |
| EP-1171625-A1 | PURIFIED \"ALTEROMONAS MACLEODII\" POLYSACCHARIDE AND ITS USES | INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER) (FR) | 2002-01-16 | — | — | EP | disclosed |
| WO-1999067411-A1 | PURIFIED ALTEROMONAS MACLEODII POLYSACCHARIDE AND ITS USES | INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER) (FR) | 1999-12-29 | — | — | WO | disclosed |
| EP-0410326-B1 | Genetic control of acetylation and pyruvylation of xanthan gum | MONSANTO CO (US) | 1998-10-21 | — | — | EP | disclosed |
| EP-0410326-A2 | Genetic control of acetylation and pyruvylation of xanthan gum | GETTY SCIENTIFIC DEVELOPMENT COMPANY (US) | 1991-01-30 | — | — | EP | disclosed |